Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether treatment with daily oral dose of AZD8529
40 mg administered over 28 days is safe, well tolerated and improves main symptoms of
schizophrenia in adult schizophrenia patients.